Tag: Dr. Stephen Salloway
Alzheimer’s drug studied in R.I. heads to FDA for approval
PROVIDENCE – An investigational Alzheimer’s disease drug studied extensively in Rhode Island has been submitted to the U.S. Food and Drug Administration for approval.
The...
Drug studied at 2 R.I. hospitals gains FDA approval for use...
PROVIDENCE – A drug studied at two Rhode Island hospitals has earned approval from the U.S. Food and Drug Administration for use in the...
Five Questions With: Dr. Stephen Salloway
Dr. Stephen Salloway heads the neurology department and Memory and Aging Program at Butler Hospital, where, as part of a study, some patients have...
Campaign aims to enlist 2K participants in Alzheimer’s research effort by...
PROVIDENCE - Butler Hospital is working toward a big goal – it is hoping to enlist 2,020 Rhode Islanders in its Alzheimer’s Prevention Registry...
- Featured Event -
